ENTRY       D07299                      Drug
NAME        Lacosamide (JAN/USAN/INN);
            Erlosamide;
            Vimpat (TN)
PRODUCT     LACOSAMIDE (VistaPharm)
            MOTPOLY XR (Aucta Pharmaceuticals)
            VIMPAT (UCB)
  GENERIC   LACOSAMIDE (ANI Pharmaceuticals)
            LACOSAMIDE (Alembic Pharmaceuticals Limited)
            LACOSAMIDE (Alembic Pharmaceuticals)
            LACOSAMIDE (American Health Packaging)
            LACOSAMIDE (Amneal Pharmaceuticals LLC)
            LACOSAMIDE (Amneal Pharmaceuticals of New York LLC)
            LACOSAMIDE (Ascend Laboratories)
            LACOSAMIDE (Aurobindo Pharma Limited)
            LACOSAMIDE (AvKARE)
            LACOSAMIDE (Breckenridge Pharmaceutical)
            LACOSAMIDE (Camber Pharmaceuticals)
            LACOSAMIDE (Camber Pharmaceuticals)
            LACOSAMIDE (Camber Pharmaceuticals)
            LACOSAMIDE (Florida Pharmaceutical Products)
            LACOSAMIDE (Fosun Pharma USA)
            LACOSAMIDE (Fresenius Kabi USA)
            LACOSAMIDE (Gland Pharma Limited)
            LACOSAMIDE (Glenmark Pharmaceuticals Inc. USA)
            LACOSAMIDE (Golden State Medical Supply)
            LACOSAMIDE (Indoco Remedies Limited)
            LACOSAMIDE (Indoco Remedies Limited)
            LACOSAMIDE (Leading Pharma)
            LACOSAMIDE (MSN LABORATORIES PRIVATE LIMITED)
            LACOSAMIDE (Major Pharmaceuticals)
            LACOSAMIDE (NorthStar RxLLC)
            LACOSAMIDE (Northstar Rx LLC.)
            LACOSAMIDE (Novadoz Pharmaceuticals LLC)
            LACOSAMIDE (PAI Holdings)
            LACOSAMIDE (Sagent Pharmaceuticals)
            LACOSAMIDE (ScieGen Pharmaceuticals)
            LACOSAMIDE (Sun Pharmaceutical Industries)
            LACOSAMIDE (Tris Pharma)
            LACOSAMIDE (Virtus Pharmaceuticals)
            LACOSAMIDE (Westminster Pharmaceuticals)
            LACOSAMIDE (XLCare Pharmaceuticals)
            LACOSAMIDE (Zydus Lifesciences Limited)
            LACOSAMIDE (Zydus Pharmaceuticals USA)
            LACOSAMIDE (Zydus Pharmaceuticals USA)
            LACOSAMIDE ORAL SOLUTION (Apotex Corp.)
            LACOSAMIDE ORAL SOLUTION (Ascend Laboratories)
FORMULA     C13H18N2O3
EXACT_MASS  250.1317
MOL_WEIGHT  250.2936
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
REMARK      Therapeutic category: 1139
            ATC code: N03AX18
            Product: D07299<JP/US>
EFFICACY    Antiepileptic, Pain relief (neuropathic)
COMMENT     Treatment of epilepsy and neuropathic pain
TARGET      SCN3A [HSA:6328] [KO:K04836]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]
INTERACTION CYP inhibition: CYP2C19 [HSA:1557]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX18 Lacosamide
                  D07299  Lacosamide (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Lacosamide
                D07299  Lacosamide (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D07299  Lacosamide (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D07299  Lacosamide
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D07299  Lacosamide
              DG01639  CYP2C19 substrate
               D07299  Lacosamide
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D07299  Lacosamide
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               D07299  Lacosamide
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D07299  Lacosamide
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN3A
                 D07299  Lacosamide (JAN/USAN/INN) &lt;JP/US&gt;
                SCN9A
                 D07299  Lacosamide (JAN/USAN/INN) &lt;JP/US&gt;
                SCN10A
                 D07299  Lacosamide (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D07299
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07299
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07299
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07299
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07299
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D07299
DBLINKS     CAS: 175481-36-4
            PubChem: 51091636
            PDB-CCD: LQO
            LigandBox: D07299
ATOM        18
            1   C8y C    21.1332  -17.9117
            2   C1b C    22.3451  -17.2121
            3   N1b N    23.5571  -17.9117
            4   C5a C    24.7689  -17.2121
            5   C1c C    25.9808  -17.9117
            6   C1b C    27.1927  -17.2121
            7   O2a O    28.4046  -17.9117
            8   C8x C    19.9214  -17.2121
            9   C8x C    18.7094  -17.9117
            10  C8x C    18.7094  -19.3111
            11  C8x C    19.9214  -20.0108
            12  C8x C    21.1332  -19.3111
            13  O5a O    24.7689  -15.8127
            14  N1b N    25.9808  -19.3110
            15  C1a C    29.6205  -17.2098
            16  C5a C    24.7564  -20.0179
            17  C1a C    23.5627  -19.3285
            18  O5a O    24.7562  -21.4198
BOND        18
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     1   8 2
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12    1  12 1
            13    4  13 2
            14    5  14 1 #Up
            15    7  15 1
            16   14  16 1
            17   16  17 1
            18   16  18 2
///
